Literature DB >> 12482523

Monoclonal antibodies in immune and inflammatory diseases.

Evangelos Andreakos1, Peter C Taylor, Marc Feldmann.   

Abstract

The era of monoclonal antibody-based therapeutics has arrived. Monoclonal antibodies of high quality targeting almost any antigen can now be engineered and manufactured in large quantities. In the clinic, monoclonal antibodies are proving to be safe and effective for the treatment of a wide range of diseases including rheumatoid arthritis, Crohn's disease, spondyloarthropathies, psoriasis and allograft rejection.

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12482523     DOI： 10.1016/s0958-1669(02)00355-5

Source DB:  PubMed          Journal:  Curr Opin Biotechnol        ISSN： 0958-1669            Impact factor:   9.740


  9 in total

1.  Opalescent appearance of an IgG1 antibody at high concentrations and its relationship to noncovalent association.

Authors:  Muppalla Sukumar; Brandon L Doyle; Jessica L Combs; Allen H Pekar
Journal:  Pharm Res       Date:  2004-07       Impact factor: 4.200

2.  Discovery and characterization of hydroxylysine in recombinant monoclonal antibodies.

Authors:  Qing Xie; Benjamin Moore; Richard L Beardsley
Journal:  MAbs       Date:  2015-12-14       Impact factor: 5.857

3.  Kruppel-like factor 2 is a transcriptional regulator of chronic and acute inflammation.

Authors:  Lalitha Nayak; Lediana Goduni; Yoichi Takami; Nikunj Sharma; Parul Kapil; Mukesh K Jain; Ganapati H Mahabeleshwar
Journal:  Am J Pathol       Date:  2013-03-13       Impact factor: 4.307

Review 4.  Antibody-initiated beneficial and harmful immune responses.

Authors:  Arpad Zsigmond Barabas; Chad Douglas Cole; Rene Lafreniere
Journal:  Immunol Res       Date:  2018-12       Impact factor: 2.829

5.  Identification of Novel Single Chain Fragment Variable Antibodies Against TNF-α Using Phage Display Technology.

Authors:  Ali Akbar Alizadeh; Maryam Hamzeh-Mivehroud; Siavoush Dastmalchi
Journal:  Adv Pharm Bull       Date:  2015-12-31

Review 6.  Management of cutaneous disorders related to inflammatory bowel disease.

Authors:  Zaira Pellicer; Jesus Manuel Santiago; Alejandro Rodriguez; Vicent Alonso; Rosario Antón; Marta Maia Bosca
Journal:  Ann Gastroenterol       Date:  2012

Review 7.  A Review of Anti-Angiogenic Targets for Monoclonal Antibody Cancer Therapy.

Authors:  Deok-Hoon Kong; Mi Ra Kim; Ji Hye Jang; Hee-Jun Na; Sukmook Lee
Journal:  Int J Mol Sci       Date:  2017-08-17       Impact factor: 5.923

Review 8.  Monoclonal Antibodies in Treating Chronic Spontaneous Urticaria: New Drugs for an Old Disease.

Authors:  Sara Manti; Alessandro Giallongo; Maria Papale; Giuseppe Fabio Parisi; Salvatore Leonardi
Journal:  J Clin Med       Date:  2022-07-30       Impact factor: 4.964

9.  Integrated Clarification and Purification of Monoclonal Antibodies by Membrane Based Separation of Aqueous Two-Phase Systems.

Authors:  Thomas Kruse; Axel Schmidt; Markus Kampmann; Jochen Strube
Journal:  Antibodies (Basel)       Date:  2019-07-02
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.